Background: Postgraduate year 2 ambulatory care pharmacy residents (PGY2 residents) may be able to improve healthcare quality by providing clinical pharmacy services provided to self-insured employer health plan patients. The objectives of this study are to describe this care delivery in a family medicine clinic, and to identify patients most likely to benefit from the service. Methods: From October 1, 2014 till June 30, 2015, comprehensive medication review was completed by PGY2 residents for patients insured by CU Anthem at the University of Colorado Westminster Family Medicine. For patients with medication-related problems (MRPs), a note was sent to the provider before the patient visit. Patient characteristics were compared in those who received a clinical pharmacy note with those who did not. Results: Sixty-eight MRPs were identified in 39 notes; 40 (58.8%) recommendations were implemented. The following Clinical Pharmacy Priority (CP2) score criteria were identified more frequently in patients with MRPs: age 65 years, diagnosis of diabetes, hypertension, chronic obstructive pulmonary disease, cardiovascular disease, blood pressure 140/90, hemoglobin A 1c >7.9%, and 6 items on the medication list. Conclusion: PGY2 residents identified and resolved numerous clinically relevant MRPs. Patient-specific criteria can be utilized to target self-insured employer health plan patients who are likely to have clinically relevant MRPs.
Background
In a self-insured employer health plan, the employer assumes all or part of the risk for payment of the medical and pharmacy claims and can therefore benefit financially when high-quality medication management services are provided. Clinical pharmacy services provided to the self-insured employer health plan population have been shown to improve chronic disease state management and influenza vaccination rates as well as reduce cardiovascular events and health-care cost. [1] [2] [3] [4] [5] [6] [7] In these studies, pharmacists have delivered care to self-insured populations in different settings using a variety of practice models. These include community pharmacies, pharmacist disease state management clinics, and within primary care provider offices. These published studies have focused primarily on chronic disease and have shown clinical pharmacy services to be a cost-effective strategy to improve the care for these patients. medication review (CMR), others have no medication management needs. There is a lack of primary literature describing which type of self-insured employer health plan patients should be targeted for CMR to optimize efficiency and effectiveness of care provided. Population health interventions targeting patients most likely to benefit from CMR provided by a clinical pharmacist are needed to continue to improve patient care quality in the evolving health-care environment.
Pharmacy residents require immersion into the clinical setting to develop competency in providing patient care. This is especially true for postgraduate year 2 (PGY2) pharmacy residents who have already completed 1 year of broad clinical training. PGY2 pharmacy residents can potentially provide high-level and cost-effective population health interventions for medication management. It is not known to what extent PGY2 pharmacy residents can contribute to the care delivery of self-insured employer health plan patients. To answer these questions, we describe a clinical pharmacy service utilizing PGY2 ambulatory care pharmacy residents embedded within a family medicine clinic to complete CMR to optimize medication management for the self-insured employer health plan patient population at the University of Colorado. This clinical pharmacy service provided a unique population health learning opportunity for the PGY2 ambulatory care residents, sought to improve patient care, and sought to build a case using pilot data to support the expansion of clinical pharmacy services to all patients with CU Anthem insurance. The primary objectives of this project are to describe the impact of the PGY2 pharmacy resident population health intervention and to identify those patients within the self-insured population who are most likely to benefit from CMR and intervention by a pharmacist.
Methods
This study was approved by the Colorado Multiple Institutional Review Board. The University of Colorado Health and Welfare Trust is a self-insured entity for employees of the University of Colorado, providing medical and pharmacy employee benefits through Anthem ("CU Anthem"). Patients receive primary care at participating providers in the Colorado region. This region includes, but is not limited to, the University of Colorado Family Medicine Clinics located in the Denver metro area. At one of the family medicine clinic sites, the University of Colorado Westminster Family Medicine Clinic, clinical pharmacy services have been embedded since August 2014. Clinical pharmacists at this site have full access to the electronic health record (EHR) and provide patient care in an interprofessional model collaboratively alongside clinic providers. This clinic is also a training site for PGY2 ambulatory care pharmacy residents ("PGY2 residents") from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. From April 1, 2015, through June 30, 2015, the service was provided by the other 2 PGY2 residents. A faculty member from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences provided oversite as the primary preceptor for the project. The PGY2 residents were oriented to the practice site and care delivery model, but then provided the care with significant independence. There was no standardized training, other than initial modeling with the preceptor for the first few weeks. To facilitate completion of these CMRs, residents were provided an automated list of patients insured by CU Anthem who had an appointment at the clinic the upcoming week. This list also contained each patient's Clinical Pharmacy Priority (CP2) score. The CP2 score utilizes patient-specific elements available in the EHR, including diagnoses of chronic disease, age, number of medications, and others, to create a score ranging from 0 to 21. 8 Previous work has shown that when used in the family medicine clinic setting, the higher the CP2 score, the more likely a patient is to have one or more medication-related problems (MRPs). 8 When one or more MRPs were identified during a CMR, the PGY2 resident wrote a consultation note in the EHR and provided this electronically to the patient's provider prior to the patient visit. The PGY2 resident also communicated face-to-face with the primary care provider whenever possible. The provider could then consider the medication recommendation(s) during the patient visit.
Statistical Analysis
Descriptive statistics were used to compare patients who received a clinical pharmacist consultation note with patients who did not receive a clinical pharmacist consultation note and are presented as mean values with interquartile ranges (IQRs) and percentages. t Test was used to compare CP2 score, age, and number of medications, and Fisher's exact test was used to evaluate differences in CP2 criteria between patients who did and did not receive a medication recommendation.
Results
The 3 PGY2 residents reviewed 280 individual patients insured by CU Anthem during the study time period. These patients were on average 39.9 years old, had an average of 5.5 medications, had an average CP2 score of 2.61, and 56.8% were female. As shown in Table 1 , almost all were less than 65 years old and patients had a low prevalence of chronic disease. After providing CMR for all 280 patients, there were 39 clinical pharmacy consultation notes written, which addressed one or more MRPs in 34 unique patients. Patients with identified MRPs had a higher CP2 score (mean: 6.6 vs 2.1, IQR: 5-9 vs 1-4, P < .0001), were older (mean age: 55.6 vs 38, IQR: 46-65 vs 28-52, P < .0001), and had a higher number of medications (mean: 9.8 vs 5, IQR: 7-13 vs 1-7, P < .0001). Table 2 shows the prevalence of CP2 score elements among the 34 patients who received a clinical pharmacy consultation note addressing MRPs. The prevalence of CP2 score elements for the 246 patients in which no MRPs were identified was also summarized. Compared to patients who did not receive a consultation note, patients who received a consultation note were more likely to be 65 years or older (23.5% vs 1.6%, P < .0001), have a diagnosis of diabetes (50% vs 5.3%, P < .0001), have a diagnosis of hypertension (65.7% vs 22.4%, P < .0001), have a diagnosis of chronic obstructive pulmonary disease (COPD; 5.9% vs 0.4%, P ¼ .04), have a diagnosis of cardiovascular disease (CVD; 11.8% vs 1.6%, P ¼ .009), have a blood pressure of 140/90 or higher (23.5% vs 7.3%, P ¼ .007), have a hemaglobin A 1c (A 1c ) greater than 7.9% (32.4% vs 0.8%, P < .0001), and were more likely to have 6 or more items on their medication list (88.2% vs 34.6%, P < .0001).
There were a total of 68 MRPs identified, with 68 medication recommendations made to the patient's primary care provider in the 39 clinical pharmacy consultation notes (Table 3) . Of these 68 medication recommendations made, 40 (58.8%) were implemented during the patient appointment. There were a variety of different drug therapy recommendations made by the PGY2 residents. The majority of these recommendations were for vaccination and optimal treatment of chronic disease with titration of drug dose or addition of medication. Recommendations to discontinue use of unnecessary drugs that increased cost and increased the likelihood of drug interactions and side effects were also provided.
Discussion
Our PGY2 ambulatory care pharmacy residents provided a high-level population health intervention to identify and resolve numerous MRPs. Targeting and improving these areas of medication use is valuable for patients, can reduce healthcare costs, and can improve health-care quality and safety. More than 40% of the recommendations made by the pharmacy residents were to provide specific vaccinations. Of these, almost all were for pneumococcal vaccination. Vaccinations are known to be an important health-care quality indicator and can also generate revenue.
The PGY2 pharmacy residents were also successful in collaborating with primary care providers to resolve the identified MRPs. Nearly 60% of the medication recommendations made by our pharmacy residents to providers were accepted. In the primary literature, the acceptance of medication recommendations by a physician is variable. However, acceptance appears to be lower (<50%) when the pharmacist is located off-site [9] [10] [11] and higher (> 50%) when the pharmacist is providing care in the same setting as the provider. [12] [13] [14] [15] The limited primary literature evaluating the pharmacy residents' contribution to clinical care has demonstrated improvement in chronic disease management, identification and resolution of drug therapy problems, and improvement in 30-day readmission rates for patients with heart failure. [16] [17] [18] [19] When pharmacy residents are providing medication recommendations to providers, the acceptance rate has been 45% in one study 18 and 90% in another. 17 In both of these studies, the pharmacy resident was embedded in the same clinical environment as the provider.
Our population health intervention model was highly successful, and this is likely due to the interprofessional model of care utilized. The higher acceptance rate of recommendations in our study is likely increased because the pharmacy residents had access to the EHR, worked directly with the primary care providers who had previously developed collaborative working relationships with embedded clinical pharmacists, and were able to communicate with patients telephonically or face-to-face in clinic. A meta-analysis has demonstrated that some of these factors can improve collaboration between the pharmacist and provider and increase pharmacist recommendation acceptance rates. 20 All of the pharmacy residents also completed PGY1 residency training and had previously acquired clinically relevant, high-level medication recommendation skills. The delivery of this care provided a favorable opportunity for PGY2 pharmacy residents to refine skills in consulting with providers following CMR.
The self-insured employer health plan patient population at the University of Colorado Westminster Family Medicine Clinic is relatively healthy. This population likely provides a representative sample of the University of Colorado selfinsured population. These patients had low prevalence of chronic disease, and most were less than 65 years old. A common challenge with population health interventions is to identify those patients who would most benefit from a given care delivery service. Despite this population's overall health, we were able to define a subgroup of patients within the population that clearly benefitted from CMR provided by a pharmacy resident. Patients receiving a medication recommendation had an overall higher CP2 score than those who did not have a medication recommendation. However, not all of the components of the CP2 score are necessary when determining which self-insured employer health plan patients were more likely to have MRPs. A diagnosis of diabetes, hypertension, COPD, and CVD, 6 or more items on the medication list, age 65 years, elevated blood pressure, and elevated A 1c all occurred more frequently in patients with an identified MRP. In total, approximately half (n ¼ 142) of the CU Anthem patients had one or more of these 8 factors, including all 34 patients in whom a drug therapy problem was identified. Providing CMR on all 142 patients with one or more of these characteristics results in identification of an MRP in 34 (23.9%) patients. This is a highyield group in that 1 of every 4 of these patients had at least 1 MRP identified. The number of patients needed to review in order to identify an MRP was less than 3 in the 77 CU Anthem patients with at least 2 of these factors (29 of 77, 42%) and only 2 in the 38 CU Anthem patients with at least 3 of these factors (20 of 38, 52.6%). These are higher yield groups in that less patients were needed to review in order to identify a patient with an MRP. In this clinical pharmacy service delivered over 9 months, a total of 280 CU Anthem patients with primary care appointments received CMR, and 34 patients (12.1%) had identified opportunities to improve medication management. CU Anthem currently insures approximately 50 000 patients. Assuming patients in this study are a good representation of the total CU Anthem population, the potential impact of this service to the entire CU Anthem population would be significant. Using these assumptions, approximately 6050 patients with CU Anthem have opportunities to improve medication management. The complexity of several chronic diseases (eg, diabetes) is increasing as is the use of newer medications (eg, glucagon-like peptide 1 [GLP-1] agonists, PCSK9 inhibitors) and costs associated with these treatments. Therefore, the need for CMR and recommendations by clinical pharmacists, including pharmacy residents, will continue to grow.
There are potential limitations to this study. This study is a description of the process of care delivered by PGY2 residents and has the inherent limitations of a retrospective cohort design. The care was delivered by 3 different PGY2 residents, A key element to the success of our intervention was that the pharmacy residents were embedded into the clinic and interprofessional collaborative working relationships had been developed with the patient's primary care provider. The fact that 40% of identified MRPs were not accepted and implemented by the provider represents an opportunity for improvement. On several occasions, the PGY2 resident would provide medication recommendations for a chronic health-care problem, but the patient had a visit for an acute problem where the chronic problem may not have been addressed. The use of collaborative practice agreements or patient covisits with the provider may improve the resolution of identified MRPs. A modified clinical pharmacy service utilizing PGY2 pharmacy residents may provide similar robust results for all targeted CU Anthem patients. This service should seek to develop collaborative working relationships with network providers and should retain the elements of access to the EHR and communication with patients. Since PGY2 residents are less costly to employ, and have been demonstrated in this study to provide high-level care with minimal standardized training and minimal preceptor oversight, this type of service could be a model to make the provision of clinical pharmacy services more costeffective and available to a larger population of patients.
Conclusion
Our PGY2 ambulatory care pharmacy residents identified numerous clinically relevant drug therapy problems for selfinsured employer health plan patients at a midsize family medicine clinic. From the CP2 score, our results indicate that a diagnosis of diabetes, hypertension, COPD, CVD, elevated blood pressure, 6 or more items on the medication list, age 65 years, and elevated A 1c are important elements to consider when targeting patients who will have a drug therapy problem that can be identified upon clinical pharmacist-provided CMR. The results of our study could be used to provide population health interventions utilizing clinical pharmacy services for patients who have the most to gain from CMR.
